Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
On May 3, we talked about a "Trump-proof" way to play China's exploding social media and e-commerce markets. That stock's already up a market-crushing 8%.
Well, I think the next global tech-trend play I've got to tell you about could do even better.
It's one of the "frontier" investment opportunities I've been so bullish on this year.
You can buy the company right here at home, but I think it's going to triple thanks to events taking place right now in one of the world’s hottest markets: India.
Every Investor Should Tap This Growth
With 1.3 billion residents, India is the globe's second-most-populous nation. And it could surpass China in as little as five years.
India logged 7% GDP growth in 2016's fourth quarter. That beat forecasts by 10%. Even if that were to slow by as much as 20%, India's economy would still be expanding twice as fast as that of the United States – but economists are predicting 7.2% growth in 2017.
In just the past decade, India's $2.2 trillion economy has leaped past Italy, Brazil, Canada, South Korea, and Russia. That means it's now the globe's seventh-largest economy – and it could move up to fifth place by 2020.
It just hit the top of a list of 30 developing economies for ease of doing business.
That kind of growth makes India one of the most enticing frontier investing markets today, a place where we can enjoy and profit from that "first-mover advantage" I've talked about. And we know high tech – a massive driver of wealth all over the world - is set to play a central role in this massive opportunity.
While India has a rich history of economic and business growth, it's equally well-known for its "threat landscape." Corruption, crime, political instability, and terrorism all scare away many investors.
That's why I've searched high and low for a way to get in on India's ferocious tech growth – a way to get on the "sadak" to wealth – without exposing ourselves to those sorts of risks.
But that still offers hope of quick triple-digit gains.
And I've finally found it…
The "Digital India" Plan Could Be a License to Print Money
India signaled a major push into high tech when Prime Minister Narendra Modi visited the United States in 2015, the first such trip by an Indian head of state in three decades.
He visited Silicon Valley to talk about his Di…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.